Trifarma Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ZOLEDRONIC ACID, with a corresponding US DMF Number 27107.
Remarkably, this DMF maintains an Active status since its submission on April 24, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 31, 2013, and payment made on May 30, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II